These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 12846341

  • 1. Efficacy and tolerability of once-daily oral therapy with telithromycin compared with trovafloxacin for the treatment of community-acquired pneumonia in adults.
    Pullman J, Champlin J, Vrooman PS.
    Int J Clin Pract; 2003 Jun; 57(5):377-84. PubMed ID: 12846341
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.
    Mathers Dunbar L, Hassman J, Tellier G.
    Clin Ther; 2004 Jan; 26(1):48-62. PubMed ID: 14996517
    [Abstract] [Full Text] [Related]

  • 6. A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.
    Sokol WN, Sullivan JG, Acampora MD, Busman TA, Notario GF.
    Clin Ther; 2002 Apr; 24(4):605-15. PubMed ID: 12017405
    [Abstract] [Full Text] [Related]

  • 7. Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin.
    Niederman MS, Chang JR, Stewart J, Nusrat R, Nieman RB.
    Curr Med Res Opin; 2004 May; 20(5):749-56. PubMed ID: 15140342
    [Abstract] [Full Text] [Related]

  • 8. Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia.
    Trémolières F, de Kock F, Pluck N, Daniel R.
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):447-53. PubMed ID: 9758291
    [Abstract] [Full Text] [Related]

  • 9. Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin for 10 days.
    Tellier G, Chang JR, Asche CV, Lavin B, Stewart J, Sullivan SD.
    Curr Med Res Opin; 2004 May; 20(5):739-47. PubMed ID: 15140341
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of telithromycin in community-acquired pneumonia caused by pneumococci with reduced susceptibility to penicillin and/or erythromycin.
    van Rensburg DJ, Fogarty C, Kohno S, Dunbar L, Rangaraju M, Nusrat R.
    Chemotherapy; 2005 Jul; 51(4):186-92. PubMed ID: 15980629
    [Abstract] [Full Text] [Related]

  • 12. Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.
    Léophonte P, File T, Feldman C.
    Respir Med; 2004 Aug; 98(8):708-20. PubMed ID: 15303634
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical and bacteriologic efficacy of telithromycin in patients with bacteremic community-acquired pneumonia.
    Carbon C, van Rensburg D, Hagberg L, Fogarty C, Tellier G, Rangaraju M, Nusrat R.
    Respir Med; 2006 Apr; 100(4):577-85. PubMed ID: 16376537
    [Abstract] [Full Text] [Related]

  • 17. Telithromycin 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia.
    Carbon C, Moola S, Velancsics I, Leroy B, Rangaraju M, Decosta P.
    Clin Microbiol Infect; 2003 Jul; 9(7):691-703. PubMed ID: 12925111
    [Abstract] [Full Text] [Related]

  • 18. Telithromycin in the treatment of pneumococcal community-acquired respiratory tract infections: a review.
    Fogarty CM, Buchanan P, Aubier M, Baz M, van Rensburg D, Rangaraju M, Nusrat R.
    Int J Infect Dis; 2006 Mar; 10(2):136-47. PubMed ID: 16183318
    [Abstract] [Full Text] [Related]

  • 19. Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials.
    Niederman MS, Chang JR, Stewart J, Asche CV, Lavin B, Nusrat R, Sullivan SD.
    Curr Med Res Opin; 2004 Jul; 20(7):969-80. PubMed ID: 15265241
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.